Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study

Concern about possible false-negative prostate biopsy histopathology findings often leads to rebiopsy. A quantitative methylation specific polymerase chain reaction assay panel, including GSTP1, APC and RASSF1, could increase the sensitivity of detecting cancer over that of pathological review alone...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of urology Jg. 189; H. 3; S. 1110
Hauptverfasser:	Stewart, Grant D, Van Neste, Leander, Delvenne, Philippe, Delrée, Paul, Delga, Agnès, McNeill, S Alan, O'Donnell, Marie, Clark, James, Van Criekinge, Wim, Bigley, Joseph, Harrison, David J
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.03.2013
Schlagworte:	Biomarkers, Tumor - analysis Biomarkers, Tumor - genetics Biopsy, Needle DNA, Neoplasm - analysis DNA, Neoplasm - genetics Epigenomics - methods Humans Male Polymerase Chain Reaction Prostate - metabolism Prostate - pathology Prostatic Neoplasms - diagnosis Prostatic Neoplasms - genetics Prostatic Neoplasms - metabolism Retrospective Studies
ISSN:	1527-3792, 1527-3792
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!